The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus
NCT ID: NCT01083420
Last Updated: 2010-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
30 participants
INTERVENTIONAL
2010-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients will rinse and expectorate 5 ml of the 1st mouthwash 4 times daily for 14 days. Subjects will complete a daily follow-up form that includes data regarding the daily intensity of pain (using VAS) caused by OLP and regarding possible side effects. After a washout period (at least 14 days) the patients will repeat the protocol with the second mouthwash.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
NCT04364555
Treatment Protocols for Patients With Symptomatic Oral Lichen Planus
NCT04673916
Micronutrients in Management of Symptomatic Oral Lichen Planus
NCT04765267
Evaluating LP-10 in Subjects With OLP
NCT06233591
Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus
NCT06428630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone
Dexamethasone 0.01% mouthwash
Dexamethasone
Dexamethasone 0.01% mouthwash
Minocycline
Minocycline 0.2% mouthwash
Minocycline
Minocycline 0.2% mouthwash
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minocycline
Minocycline 0.2% mouthwash
Dexamethasone
Dexamethasone 0.01% mouthwash
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheba Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noam Yarom, DMD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-09-7335-NY-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.